Cargando…
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
BACKGROUND: Accumulating evidence shows that a propensity towards a pro-inflammatory status in the brain plays an important role in schizophrenia. Anti-inflammatory drugs might compensate this propensity. This study provides an update regarding the efficacy of agents with some anti-inflammatory acti...
Autores principales: | Çakici, N., van Beveren, N. J. M., Judge-Hundal, G., Koola, M. M., Sommer, I. E. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763537/ https://www.ncbi.nlm.nih.gov/pubmed/31439071 http://dx.doi.org/10.1017/S0033291719001995 |
Ejemplares similares
-
M39. AN UPDATE ON THE EFFICACY OF ANTI-INFLAMMATORY AGENTS FOR PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS
Publicado: (2020) -
Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021) -
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
por: Çakici, Nuray, et al.
Publicado: (2021) -
Cytokines in Schizophrenia: Hope or Hype?
por: Koola, Maju Mathew
Publicado: (2016) -
Methodological Issues in Cytokine Measurement in Schizophrenia
por: Koola, Maju Mathew
Publicado: (2016)